Filed by Akebia Therapeutics, Inc.
Pursuant to Rule 425 under the Securities Act of 1933
Commission File No.: 001-36352
Subject Company: Keryx Biopahrmaceuticals, Inc.
Commission File No.: 000-30929
Date: June 28, 2018
The following are social media communications by Akebia Therapeutics, Inc. (Akebia) that discuss the proposed merger of Akebia and Keryx Biopharmaceuticals, Inc.
Social Media Communications by Akebia
The following communication was posted on June 28, 2018 by Akebia on Twitter:
The following communication was posted on June 28, 2018 by Akebia at www.linkedin.com: